#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Myelodysplastic syndrome Cervix carcinoma Lung adenocarcinoma Renal cancer metastatic Adrenocortical carcinoma Antithrombin III deficiency Inborn error of metabolism Cardiac failure acute Pituitary-dependent Cushing's syndrome Autoimmune hepatitis B-cell type acute leukaemia Leiomyosarcoma recurrent Acute leukaemia Pleomorphic leiomyosarcoma Oesophageal adenocarcinoma stage II More trials…
Learn about Rare Diseases

Adrenocortical carcinoma – Treatment Isodicentric chromosome 15 syndrome – Diagnostics Alagille syndrome – Diagnostics Prader-Willi syndrome – Basic Information Bronchopulmonary dysplasia – Treatment Progressive multifocal leukoencephalopathy – Basic Information Leukoencephalopathy – Treatment Haemophilia Propionic acidaemia – Trials in Disease Sarcoidosis – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Methylone Meropenem Trihydrate Sunitinib AZD3632 Dipyridamole Tuparstobart Insulin Glargine Inotuzumab Ozogamicin Sodium Thiosulfate Cebsulfase Alfa Asp1570 Nirmatrelvir Tas3351 Efinopegdutide 64Cu-Dota-Ae105 Technetium (99Mtc) Vibozilimod Flutemetamol (18F) Nortriptyline Zoledronic Acid Monohydrate More therapies…

Learn about Your Condition

Hypoparathyroidism Bladder cancer Skin disorder Proteinuria Amyloidosis Post-acute COVID-19 syndrome Peritoneal sarcoma Albright's disease Wolfram syndrome Oesophageal food impaction Keratosis follicular Graft infection Tuberculosis Post procedural swelling Oral lichen planus More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Progressive relapsing multiple sclerosis

Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ozanimod
Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
+17
Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Not yet recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Progressive relapsing multiple sclerosis

Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies